Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Prevalence of the Mutations Responsible for Glanzmann Thrombasthenia in Horses in Brazil

Texto completo
Autor(es):
Leite, Raissa O. [1] ; Ferreira, Julia F. [1] ; Araujo, Cesar E. T. [1] ; Delfiol, Diego J. Z. [2] ; Takahira, Regina K. [1] ; Borges, Alexandre S. [1] ; Oliveira-Filho, Jose P. [1]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Sao Paulo State Univ, UNESP, Sch Vet Med & Anim Sci, Dept Vet Clin Sci, BR-18618681 Botucatu, SP - Brazil
[2] Univ Fed Uberlandia, Sch Vet Med, BR-38405320 Uberlandia, MG - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: ANIMALS; v. 9, n. 11 NOV 2019.
Citações Web of Science: 0
Resumo

Simple Summary Hereditary bleeding disorders occur in different species due to mutations in genes coding specific hemostatic proteins leading to alterations in their synthesis, or to the production of non-functional proteins which leads to impairment of hemostasis. Some of these disorders have been described in horses, i.e., Von Willebrand disease (VWD), hemophilia A, and Glanzmann's thrombasthenia (GT). GT is an inherited disease characterized by hemorrhage and has been described in different species including horses of varied breeds (Thoroughbred, Standardbred, Oldenburg, Peruvian Paso, and Quarter Horse). There are two different mutations described in horses a single guanine to cytosine substitution (CGG for CCG) and a 10 base pair deletion in the ITGA2B gene. Abstract Glanzmann's thrombasthenia (GT) is an autosomal recessive inherited disorder characterized by changes in platelet aggregation, leading to hemorrhage and epistaxis. To date, two independent mutations have been described in horses and associated with this disorder, a point mutation (c.122G > C) and a 10-base-pair deletion (g.1456\_1466del) in the Integrin subunit alpha2 beta gene (ITGA2B) of horses of different breeds (Quarter Horse, Thoroughbred, Oldenburg, and Peruvian Paso). ITGA2B codifies the alpha IIb subunit of the alpha IIb beta 3 integrin, also termed platelet fibrinogen receptor. Horses with GT have been diagnosed in the USA, Canada, Japan, and Australia. However, there are no studies on the prevalence of GT in horses. The aim of this study is to evaluate the prevalence of the mutations responsible for GT in horses in Brazil. A total of 1053 DNA samples of clinically healthy Quarter Horse (n = 679) and Warmblood horses (n = 374) were used. DNA fragments were amplified by PCR and sequenced. The genotype of each animal was analyzed and compared to the nucleotide sequence of the ITGA2B gene found on GenBank (TM). There were no carriers in the analyzed samples, that is, all animals tested were wild type. Therefore, under the conditions in which this study was carried out, it can be inferred that GT seems to be extremely rare in the population of Quarter Horses and Warmbloods in Brazil, although it is not possible to affirm that there are no horses carrying mutated alleles in Brazil. (AU)

Processo FAPESP: 17/18757-1 - Prevalência da deleção de 10 pares de base no gene ITGA2B, responsável pela Trombastenia de Glanzmann, em equinos Quarto de Milha no Brasil
Beneficiário:Julia Franco Ferreira
Modalidade de apoio: Bolsas no Brasil - Iniciação Científica